345 related articles for article (PubMed ID: 30898806)
1. Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.
Allan B; Closson K; Collins AB; Kibel M; Pan S; Cui Z; McLinden T; Parashar S; Lima VD; Chia J; Yip B; Barrios R; Montaner JSG; Hogg RS
BMJ Open; 2019 Mar; 9(3):e023957. PubMed ID: 30898806
[TBL] [Abstract][Full Text] [Related]
2. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
3. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.
Patterson S; Cescon A; Samji H; Cui Z; Yip B; Lepik KJ; Moore D; Lima VD; Nosyk B; Harrigan PR; Montaner JS; Shannon K; Wood E; Hogg RS
Int J Epidemiol; 2015 Feb; 44(1):58-67. PubMed ID: 24639444
[TBL] [Abstract][Full Text] [Related]
4. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
[TBL] [Abstract][Full Text] [Related]
5. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme.
Moore DM; Zhang W; Yip B; Genebat M; Lima VD; Montaner JS; Hogg RS
HIV Med; 2010 May; 11(5):299-307. PubMed ID: 20002777
[TBL] [Abstract][Full Text] [Related]
6. Outpatient pharmacy care and HIV viral load response among patients on HAART.
Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
[TBL] [Abstract][Full Text] [Related]
7. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
[TBL] [Abstract][Full Text] [Related]
8. Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.
Hentzien M; Dramé M; Allavena C; Jacomet C; Valantin MA; Cabié A; Cuzin L; Rey D; Pugliese P; Bani-Sadr F;
J Nutr Health Aging; 2016 Apr; 20(4):408-14. PubMed ID: 26999241
[TBL] [Abstract][Full Text] [Related]
9. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
10. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
Wood E; Hogg RS; Lima VD; Kerr T; Yip B; Marshall BD; Montaner JS
JAMA; 2008 Aug; 300(5):550-4. PubMed ID: 18677027
[TBL] [Abstract][Full Text] [Related]
12. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.
Kouanda S; Meda IB; Nikiema L; Tiendrebeogo S; Doulougou B; Kaboré I; Sanou MJ; Greenwell F; Soudré R; Sondo B
AIDS Care; 2012; 24(4):478-90. PubMed ID: 22148973
[TBL] [Abstract][Full Text] [Related]
13. Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.
Palella FJ; Baker RK; Buchacz K; Chmiel JS; Tedaldi EM; Novak RM; Durham MD; Brooks JT;
AIDS; 2011 Sep; 25(15):1865-76. PubMed ID: 21811144
[TBL] [Abstract][Full Text] [Related]
14. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.
Lourenço L; Samji H; Nohpal A; Chau W; Colley G; Lepik K; Barrios R; Lima V; Hogg RS; Montaner J; Kesselring S; Moore DM
HIV Med; 2015 Jul; 16(6):337-45. PubMed ID: 25721157
[TBL] [Abstract][Full Text] [Related]
15. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
[TBL] [Abstract][Full Text] [Related]
16. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011.
Nosyk B; Montaner JS; Yip B; Lima VD; Hogg RS;
Med Care; 2014 Apr; 52(4):362-9. PubMed ID: 24848208
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013.
Angdembe MR; Rai A; Bam K; Pandey SR
PLoS One; 2019; 14(4):e0215776. PubMed ID: 31013320
[TBL] [Abstract][Full Text] [Related]
19. Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006-2020.
Niu D; Xiao T; Chen Y; Tang H; Chen F; Cai C; Qin Q; Zhao D; Jin Y; Wang S; Hou Y; Lu Z; Yang L; Liu H; Xie D; Zou H; Lyu F
BMC Infect Dis; 2023 Mar; 23(1):186. PubMed ID: 36991355
[TBL] [Abstract][Full Text] [Related]
20. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
